Jeffrey Allen Morris - 08 May 2023 Form 4 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Role
10%+ Owner
Signature
/s/ Jeffrey Allen Morris
Issuer symbol
PVCT
Transactions as of
08 May 2023
Net transactions value
+$540,223
Form type
4
Filing time
09 May 2023, 16:50:51 UTC
Previous filing
28 Mar 2023
Next filing
14 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PVCT Series D-1 Convertible Preferred Stock Conversion of derivative security $540,223 +188,757 +5% $2.86* 3,995,747 08 May 2023 Direct F3
holding PVCT Common Stock 12,000,000 08 May 2023 Direct F1
holding PVCT Common Stock 6,500,000 08 May 2023 By IRA F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person has sole voting and dispositive power over 12,000,000 shares of Common Stock.
F2 The reporting person has sole voting and dispositive power over 6,500,000 shares of Common Stock owned through an IRA retirement plan.
F3 The reporting person has sole voting and dispositive power over 3,995,747 shares of Series D-1 Convertible Preferred Stock, convertible into 39,957,470 shares of Common Stock.